Endpoints News recaps Boston China biotech debate on industry’s China outlook

Last week Endpoints News hosted a live debate in Boston that brought together leading voices in biopharma to discuss China’s growing role in the industry.

The panel featured executives and investors including the CEO of Roivant, the founder of Strand Therapeutics, a capital‑managing partner, an MIT professor, the CEO of Ginkgo Bioworks, and a Pfizer special advisor. They examined how China’s rise is influencing company strategies, government policy, and investor priorities.

Audio and video recordings of the discussion have been made available online for those who missed the event, with links provided on the Endpoints News platform and podcast channels.

Organizers indicated that this conversation is just the beginning and that a follow‑up session is planned for mid‑September.